Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.670
+0.100 (3.89%)
Jun 2, 2026, 2:42 PM EDT - Market open

Fortress Biotech Revenue

Fortress Biotech had revenue of $16.04M in the quarter ending March 31, 2026, with 22.06% growth. This brings the company's revenue in the last twelve months to $66.16M, up 14.50% year-over-year. In the year 2025, Fortress Biotech had annual revenue of $63.26M with 9.69% growth.

Revenue (ttm)
$66.16M
Revenue Growth
+14.50%
P/S Ratio
1.38
Revenue / Employee
$848,218
Employees
78
Market Cap
88.69M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202563.26M5.59M9.69%
Dec 31, 202457.68M-26.84M-31.76%
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 201936.63M9.75M36.26%
Dec 31, 201826.88M9.64M55.88%
Dec 31, 201717.25M11.09M180.09%
Dec 31, 20166.16M5.29M613.44%
Dec 31, 2015863.00K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell29.93M
Atara Biotherapeutics23.14M
MindWalk Holdings20.70M
NeurAxis4.28M
Rallybio858.00K
eXoZymes-700.00
Revenue Rankings